简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2015-12-14 18:30 Initiation of first multinational study to evaluate safety of OFEV® (nintedanib) with add-on of pirfenidone in patients with IPF
2015-12-14 16:03 Recruitment of Purchase Participants for Korean Medical Device Manufacturer SDE
2015-12-14 12:29 Panasonic Introduced Its Tomato-picking Robot and Parallel Link Robot at International Robot Exhibition 2015
2015-12-14 09:53 New Investment into Pharmaron Positions the Company for Future Growth
2015-12-11 15:56 Quintiles Launches Suite of Services to Integrate Asset Development Planning
2015-12-10 09:51 Merck and Pfizer Initiate Two Phase III Studies of Investigational Immunotherapy Avelumab in Advanced Gastric and Gastro-esophageal Junction Cancers
2015-12-09 15:20 Takeda and Cour Partner to Develop Novel Therapies for Celiac Disease and Other Gastrointestinal Diseases
2015-12-09 10:56 ARxIUM Selects Additional Distributors of RIVA Automated Compounding System for Asia-Pacific Region
2015-12-09 10:21 New Phase III study of nintedanib in people with systemic sclerosis and lung fibrosis
2015-12-09 10:10 Arcadia Biosciences and BGI to Create Global Non-GM Genetic Resource for Rice
2015-12-08 14:19 Takeda Presents Data from Phase 3 TOURMALINE-MM1 Study for NINLARO® (ixazomib), First and Only Once-Weekly Oral Proteasome Inhibitor Recently Approved for Multiple Myeloma
2015-12-07 16:02 Takeda Reports Five-Year Overall Survival Data for ADCETRIS® (Brentuximab Vedotin) Demonstrate Durable Remissions in Relapsed/Refractory Hodgkin Lymphoma
2015-12-04 17:59 Samsung Bioepis' RENFLEXIS® Infliximab Biosimilar Receives Regulatory Approval in Korea
2015-12-04 16:18 Allied World Announces Enhanced Coverage Options for Healthcare Organizations
2015-12-03 10:39 Boehringer Ingelheim and MD Anderson Cancer Center join forces to discover new treatment approaches for pancreatic cancer
2015-12-02 14:07 The Asian Acne Board and Galderma Join Forces to Improve Understanding and Management of Acne
2015-12-01 13:09 Teva and Takeda Establish Unique Partnership to Meet the Wide-Ranging Needs of Patients and Growing Importance of Generic Medicines Use in Japan
2015-12-01 09:19 Lung cancer experts call for improved EGFR mutation testing to allow all eligible NSCLC patients access to personalised treatment
2015-11-26 17:49 Praxbind® (idarucizumab) approved in European Union for the specific reversal of Pradaxa® (dabigatran etexilate)
2015-11-24 10:01 ADDING MULTIMEDIA U.S. FDA Approves Takeda’s NINLARO® (ixazomib), the First and Only Oral Proteasome Inhibitor to Treat Multiple Myeloma

Business Wire Weibo

Press Releases

Latest Releases